| Financial Year |
March 31 2023 |
| Monetary Funds |
280,171,294.59 |
| Held-for-trading Financial Assets |
158,379,921.00 |
| Notes Receivable |
589,860.18 |
| Accounts Receivable |
130,865,181.69 |
| Advances to Suppliers |
2,771,956.23 |
| Other Receivables |
3,812,520.28 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
107,232,543.07 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
14,905,365.68 |
| Total Current Assets |
698,728,642.72 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
439,238,262.77 |
| Under-construction Projects |
215,215,156.48 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
152,724,567.11 |
| R&D expenses |
-- |
| Goodwill |
19,194,738.42 |
| Long-Term Deferred and Prepaid Expenses |
2,555,139.20 |
| Deferred Income Tax Assets |
24,892,046.21 |
| Other Non-Current Assets |
8,514,574.58 |
| Sub-Total of Non-Current Assets |
906,755,813.99 |
| Total Assets |
1,605,484,456.71 |
| Short-Term Loans |
60,037,800.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
161,774,608.43 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
20,070,275.52 |
| Taxes Payable |
2,423,367.83 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
7,121,050.11 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
17,554,225.67 |
| Other Current Liabilities |
102,357.76 |
| Sub-Total of Current Liabilities |
272,740,365.29 |
| Long-term Loans |
94,774,000.00 |
| Bonds Payable |
315,162,762.38 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
433,677,763.63 |
| Total Liabilities |
706,418,128.92 |
| Paid-In Capital(Or Share Stock) |
155,550,619.00 |
| Capital Surplus |
403,439,325.56 |
| Surplus Reserve |
59,478,674.12 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
279,775,161.40 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
899,066,327.79 |
| Owner's Equity（Stockholder's Equity） |
899,066,327.79 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,605,484,456.71 |
